home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

How A Neurodegenerative Disease Gene Kills Neurons

 
  December, 27 2005 7:06
your information resource in human molecular genetics
 
     
Although amyotrophic lateral sclerosis (ALS) is linked to mutations in a particular gene, how these mutations cause disease symptoms has been unclear. Motor neurons secrete a mutant protein produced from this gene, setting off a chain of events that leads to cell death, reports a paper in the January issue of Nature Neuroscience.

ALS (or Lou Gehrig's disease) leads to paralysis from the death of motor neurons in the spinal cord and brainstem. It is incurable, and patients typically die within three to five years of disease onset. Only 5-10% of ALS cases are inherited, but some such patients have mutations in the gene that encodes a protein called superoxide dismutase (SOD1), an antioxidant enzyme.

Most of our current knowledge about ALS comes from analysis of mice with mutations of the SOD1 gene. In these mice, in addition to the motor neuron dysfunction, non-neuronal cells -- such as microglia -- also contribute to disease development. Jean-Pierre Julien and colleagues now suggest how microglia may contribute to disease development. They find that mutant SOD1 in motor neurons can bind to chromogranins, a family of proteins stored in secretory vesicles in neurons and microglia. When these secretory vesicles release their contents, mutant SOD1 is released into the extracellular space and binds to microglia, causing these cells in turn to release cell death-inducing molecules such as nitric oxide, which trigger motor neuron death. These results therefore provide a better understanding of how ALS symptoms develop by describing how SOD1 mutation can lead to motor neuron death.

Author contact:

Jean-Pierre Julien (Laval University, Montreal, Canada)
E-mail: jean-pierre.julien@crchul.ulaval.ca

Additional contact for comment on paper:

Michael Sendtner (University of Wuerzburg, Germany)
E-mail: sendtner@mail.uni-wuerzburg.de

Abstract available online.

(C) Nature Neuroscience press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.